TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Octapharma AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,598,217
|
2,389,392
|
2,084,988 |
| Financial expenses |
25,531
|
119
|
11,947 |
| Earnings before taxes |
101,676
|
180,438
|
84,381 |
| EBITDA |
302,615
|
382,220
|
312,079 |
| Total assets |
2,778,406
|
1,828,075
|
1,409,079 |
| Current assets |
1,381,094
|
664,648
|
444,974 |
| Current liabilities |
451,722
|
379,436
|
359,203 |
| Equity capital |
1,187,723
|
1,162,768
|
1,020,582 |
| - share capital |
25,000
|
25,000
|
25,000 |
| Employees (average) |
989
|
1,065
|
984 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
42.7%
|
63.6%
|
72.4% |
| Turnover per employee |
2,627
|
2,244
|
2,119 |
| Profit as a percentage of turnover |
3.9%
|
7.6%
|
4.0% |
| Return on assets (ROA) |
4.6%
|
9.9%
|
6.8% |
| Current ratio |
305.7%
|
175.2%
|
123.9% |
| Return on equity (ROE) |
8.6%
|
15.5%
|
8.3% |
| Change turnover |
208,825
|
304,404
|
296,896 |
| Change turnover % |
9%
|
15%
|
17% |
| Chg. No. of employees |
-76
|
81
|
102 |
| Chg. No. of employees % |
-7%
|
8%
|
12% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.